Synvista Therapeutics, Inc.
OTC: SYNI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Employees
- 9
- Headquarters
- Parsippany, United States
- IPO year
- 2000
- Market cap
- $3.0
Loading SYNI…
Loading profile data…Frequently asked questions about SYNI
What does Synvista Therapeutics, Inc. (SYNI) do?
Synvista Therapeutics, Inc. functions as a biopharmaceutical company dedicated to creating both diagnostic tools and therapeutic drugs. Its core objective is to identify and provide treatment options for diabetic patients who are at an elevated risk of developing cardiovascular disease. The company's product portfolio includes ALT-2074, a glutat...
Where does SYNI trade?
Synvista Therapeutics, Inc. (SYNI) trades on the Other OTC.
What sector is SYNI in?
Synvista Therapeutics, Inc. (SYNI) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Where is Synvista Therapeutics, Inc. headquartered?
Synvista Therapeutics, Inc. is headquartered in United States.
Does SYNI pay a dividend?
Synvista Therapeutics, Inc. (SYNI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SYNI go public?
Synvista Therapeutics, Inc. (SYNI) completed its initial public offering in 2000.